Katherine A. Scilla

Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy

Katherine A. Scilla, Søren M. Bentzen, Vincent K. Lam et al. · The Oncologist · 2017 · 103 citations · Full text

Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)

Vincent K. Lam, Søren M. Bentzen, Pranshu Mohindra et al. · Lung Cancer · 2016 · 90 citations

Obesity, Medicine, Long-term Improved Survival +5

Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection

Katherine A. Scilla, Dan P. Zandberg, Søren M. Bentzen et al. · Lung Cancer · 2018 · 15 citations

Human Immunodeficiency Virus, Medicine, Human Retrovirus +8

NTRK and NRG1 gene fusions in advanced non-small cell lung cancer (NSCLC)

Alessandro Russo, Ana Rita Lopes, Katherine A. Scilla et al. · Precision Cancer Medicine · 2020 · 13 citations

Ntrk-rearranged Nsclc, Pathology, Cancer Biology +16

Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non–small-cell Lung Cancer Treated With Curative Intent

Stephanie R. Rice, Melissa A.L. Vyfhuis, Katherine A. Scilla et al. · Clinical Lung Cancer · 2019 · 11 citations

Prognostic Evaluation, Curative Intent, Overall Survival +8